ASX Share rice
Fri 14 Aug 2020 - 09:56:pm (Sydney)

IMU Share Price

IMUGENE LIMITEDIMUPharmaceuticals, Biotechnology & Life Sciences

IMU Company Information


Imugene Limited





GIC Industry:


GIC Sub Industry:



37 Bligh Street Sydney Australia 2000


61 3 9824 5254

Exec. Chairman:

Mr. Paul Edward-Alexander Hopper

CEO, MD & Exec. Director:

Ms. Leslie Chong

Chief Technology Officer:

Dr. Nicholas J. Ede

Chief Medical Officer:

Dr. Mark T. Marino

CFO & Joint Company Sec.:

Mr. Phillip Allen Hains

Company Overview:

Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; and B-Vaxx, a cancer vaccine to treat tumors that over-express the HER2/neu receptor. Imugene Limited was incorporated in 1986 and is headquartered in Sydney, Australia.

IMU Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


IMU CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


IMU Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Interest Expense:


Total Revenue:


Total Operating Expenses:


IMU Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:


Other Assets:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities (Other):


Non Current Liabilities Total:


IMU Share Price History

IMU News

23 May, 2020
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a...
09 Apr, 2020
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
24 Feb, 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
08 Jan, 2020
Leslie Chong has been the CEO of Imugene Limited (ASX:IMU) since 2016. This report will, first, examine the CEO...
13 Nov, 2019
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
27 Sep, 2019
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...